New drug trial aims to keep aggressive pancreatic cancer in check
NCT ID NCT07344220
Summary
This study is testing an experimental drug called DZ-002 as a maintenance therapy for adults with metastatic pancreatic cancer. The goal is to see if giving DZ-002 after successful initial chemotherapy can help control the cancer longer and prevent it from worsening. Researchers will test three different doses to find the safest and most effective one, and participants will receive the drug weekly through an IV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
Conditions
Explore the condition pages connected to this study.